EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C29H40N8O3S |
| Net Charge | 0 |
| Average Mass | 580.759 |
| Monoisotopic Mass | 580.29441 |
| SMILES | COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1 |
| InChI | InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34) |
| InChIKey | MGGBYMDAPCCKCT-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1). EC 6.1.1.6 (lysine--tRNA ligase) inhibitor An EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor that specifically inhibits the action of lysine-tRNA ligase (EC 6.1.1.6). |
| Applications: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ASP-3026 (CHEBI:167650) has role antimalarial (CHEBI:38068) |
| ASP-3026 (CHEBI:167650) has role antineoplastic agent (CHEBI:35610) |
| ASP-3026 (CHEBI:167650) has role apoptosis inducer (CHEBI:68495) |
| ASP-3026 (CHEBI:167650) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434) |
| ASP-3026 (CHEBI:167650) has role EC 6.1.1.6 (lysine—tRNA ligase) inhibitor (CHEBI:167677) |
| ASP-3026 (CHEBI:167650) is a N-methylpiperazine (CHEBI:46920) |
| ASP-3026 (CHEBI:167650) is a aromatic amine (CHEBI:33860) |
| ASP-3026 (CHEBI:167650) is a diamino-1,3,5-triazine (CHEBI:38170) |
| ASP-3026 (CHEBI:167650) is a monomethoxybenzene (CHEBI:25235) |
| ASP-3026 (CHEBI:167650) is a piperidines (CHEBI:26151) |
| ASP-3026 (CHEBI:167650) is a secondary amino compound (CHEBI:50995) |
| ASP-3026 (CHEBI:167650) is a sulfone (CHEBI:35850) |
| IUPAC Name |
|---|
| N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propan-2-ylsulfonyl)phenyl]-1,3,5-triazine-2,4-diamine |
| Synonyms | Source |
|---|---|
| 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine | ChEBI |
| ASP 3026 | ChemIDplus |
| ASP3026 | ChemIDplus |
| N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:1097917-15-1 | ChemIDplus |
| Citations |
|---|